Bleichroeder Sponsor 1 LLC has filed an amendment to its Schedule 13G, detailing its ownership stakes in Merlin, Inc. The update, filed on November 10, 2026, is significant as it reflects changes in the beneficial ownership of shares following a business combination involving the company. This filing is important for stakeholders as it provides insights into the voting power and investment control held by key individuals within the firm.

Background

Bleichroeder Sponsor 1 LLC is a Delaware limited liability company. The firm is involved in investment management and has reported its holdings in Merlin, Inc., which operates in the services sector with a focus on computer integrated systems design. The recent filings indicate a transition from a previous entity, Inflection Point Acquisition Corp. IV, to its current name following a merger with Merlin Labs, Inc.

What the Filing Says

The filing states, "Bleichroeder Sponsor 1 LLC, Andrew Gundlach, and Michel Combes are filing this Amendment No. 2 on Schedule 13G... in connection with the closing of the business combination between the Issuer and Merlin Labs, Inc." The amendment highlights that Bleichroeder Sponsor 1 LLC currently holds no shares directly but has significant influence through its managing members.

Impact

This update may affect various stakeholders, including current and potential investors in Merlin, Inc. The filing indicates that Andrew Gundlach holds shared voting power over 100,000 shares, while Michel Combes has shared voting power over 1,143,333 shares. However, Combes has sold all his shares after the reporting period, which may impact perceptions of the company's stability and governance.

What's Next

The filing does not say what happens next.